Shah MI, Ostermayer DG, Browne LR, et al. Multicenter evaluation of prehospital seizure management in children. Prehosp Emerg Care. 2021;25(4):475-86.
Zeidan S, Rohaut B, Outin H, et al. Not all patients with convulsive status epilepticus intubated in pre-hospital settings meet the criteria for refractory status epilepticus. Seizure. 2021;88:29-35.
Kim D, Kim JM, Cho YW, et al. Antiepileptic drug therapy for status epilepticus. J Clin Neurol. 2021;17(1):11-9.
Vespa PM, Olson DM, John S, et al. Evaluating the clinical impact of rapid response electroencephalography: The decide multicenter prospective observational clinical study. Crit Care Med. 2020;48(9):1249-57.
Vasquez A, Gaínza-Lein M, Abend NS, et al. First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020;95(19):e2683-e96.
Lee SK. Diagnosis and treatment of status epilepticus. J Epilepsy Res. 2020;10(2):45-54.
Handral A, Veerappa BG, Gowda VK, et al. Levetiracetam versus fosphenytoin in pediatric convulsive status epilepticus: A randomized controlled trial. J Pediatr Neurosci. 2020;15(3):252-6.
Guterman EL, Sanford JK, Betjemann JP, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology. 2020;95(24):e3203-e12.
Chamberlain JM, Kapur J, Shinnar S, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group: A double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217-24.
Appleton RE, Rainford NE, Gamble C, et al. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: The eclipse RCT. Health Technol Assess. 2020;24(58):1-96.
Amorim E, McGraw CM, Westover MB. A theoretical paradigm for evaluating risk-benefit of status epilepticus treatment. J Clin Neurophysiol. 2020;37(5):385-92.
Yazbeck M, Sra P, Parvizi J. Rapid response electroencephalography for urgent evaluation of patients in community hospital intensive care practice. J Neurosci Nurs. 2019;51(6):308-12.
Lyttle MD, Rainford NEA, Gamble C, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (eclipse): A multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125-34.
Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103-13.
Dalziel SR, Borland ML, Furyk J, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (consept): An open-label, multicentre, randomised controlled trial. Lancet. 2019;393(10186):2135-45.
Carey JM, Studnek JR, Browne LR, et al. Paramedic-identified enablers of and barriers to pediatric seizure management: A multicenter, qualitative study. Prehosp Emerg Care. 2019;23(6):870-81.
Vasquez A, Gaínza-Lein M, Sánchez Fernández I, et al. Hospital emergency treatment of convulsive status epilepticus: Comparison of pathways from ten pediatric research centers. Pediatr Neurol. 2018;86:33-41.
Marino MC, Ostermayer DG, Mondragon JA, et al. Improving prehospital protocol adherence using bundled educational interventions. Prehosp Emerg Care. 2018;22(3):361-9.
19. Marawar R, Basha M, Mahulikar A, et al. Updates in refractory status epilepticus. Crit Care Res Pract. 2018;2018:9768949.
Gaínza-Lein M, Sánchez Fernández I, Jackson M, et al. Association of time to treatment with shortterm outcomes for pediatric patients with refractory convulsive status epilepticus. JAMA Neurol. 2018;75(4):410-8.
Verrotti A, Ambrosi M, Pavone P, Striano P. Pediatric status epilepticus: Improved management with new drug therapies? Expert Opin Pharmacother. 2017;18(8):789-98.
Remick K, Redgate C, Ostermayer D, et al. Prehospital glucose testing for children with seizures: A proposed change in management. Prehosp Emerg Care. 2017;21(2):216-21.
Hoyle JD, Jr., Crowe RP, Bentley MA, et al. Pediatric prehospital medication dosing errors: A national survey of paramedics. Prehosp Emerg Care. 2017;21(2):185-91.
Smith DM, McGinnis EL, Walleigh DJ, Abend NS. Management of status epilepticus in children. J Clin Med. 2016;5(4).
Shah MI, Carey JM, Rapp SE, et al. Impact of high-fidelity pediatric simulation on paramedic seizure management. Prehosp Emerg Care. 2016;20(4):499-507.
İşgüder R, Güzel O, Ceylan G, et al. A comparison of intravenous levetiracetam and valproate for the treatment of refractory status epilepticus in children. J Child Neurol. 2016;31(9):1120-6.
Welch RD, Nicholas K, Durkalski-Mauldin VL, et al. Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015;56(2):254-62.
Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus–report of the ilae task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515-23.
Mundlamuri RC, Sinha S, Subbakrishna DK, et al. Management of generalised convulsive status epilepticus (se): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam–pilot study. Epilepsy Res. 2015;114:52-8.
Momen AA, Azizi Malamiri R, Nikkhah A, et al. Efficacy and safety of intramuscular midazolam versus rectal diazepam in controlling status epilepticus in children. Eur J Paediatr Neurol. 2015;19(2):149-54.
Khongkhatithum C, Thampratankul L, Wiwattanadittakul N, Visudtibhan A. Intravenous levetiracetam in thai children and adolescents with status epilepticus and acute repetitive seizures. Eur J Paediatr Neurol. 2015;19(4):429-34.
Kämppi L, Mustonen H, Soinila S. Factors related to delays in pre-hospital management of status epilepticus. Neurocrit Care. 2015;22(1):93-104.
Harini C, Nagarajan E, Kimia AA, et al. Utility of initial EEG in first complex febrile seizure. Epilepsy Behav. 2015;52(Pt A):200-4.
Alford EL, Wheless JW, Phelps SJ. Treatment of generalized convulsive status epilepticus in pediatric patients. J Pediatr Pharmacol Ther. 2015;20(4):260-89.
Seinfeld S, Shinnar S, Sun S, et al. Emergency management of febrile status epilepticus: Results of the FEBSTAT study. Epilepsia. 2014;55(3):388-95.
Kim JS, Lee JH, Ryu HW, et al. Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus. Pediatr Emerg Care. 2014;30(8):525-8.
Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: A randomized clinical trial. JAMA. 2014;311(16):1652-60.
Thakker A, Shanbag P. A randomized controlled trial of intranasal-midazolam versus intravenous- diazepam for acute childhood seizures. J Neurol. 2013;260(2):470-4.
Silbergleit R, Lowenstein D, Durkalski V, Conwit R. Lessons from the rampart study–and which is the best route of administration of benzodiazepines in status epilepticus. Epilepsia. 2013;54 Suppl 6(0 6):74-7.
Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591-600.
Nordli DR, Jr., Moshé SL, Shinnar S, et al. Acute EEG findings in children with febrile status epilepticus: Results of the FEBSTAT study. Neurology. 2012;79(22):2180-6.
Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: A randomized, open labeled pilot study. J Neurol. 2012;259(4):645-8.
McTague A, Kneen R, Kumar R, et al. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: Experience from a children’s hospital. Seizure. 2012;21(7):529-34.
Malamiri RA, Ghaempanah M, Khosroshahi N, et al. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: A randomised trial. Eur J Paediatr Neurol. 2012;16(5):536-41.
Javadzadeh M, Sheibani K, Hashemieh M, Saneifard H. Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: A randomized clinical trial. Iran J Pediatr. 2012;22(1):1-8.
Silbergleit R, Lowenstein D, Durkalski V, Conwit R. Rampart (rapid anticonvulsant medication prior to arrival trial): A double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia. 2011;52 Suppl 8(Suppl 8):45-7.
Shearer P, Riviello J. Generalized convulsive status epilepticus in adults and children: Treatment guidelines and protocols. Emerg Med Clin North Am. 2011;29(1):51-64.
Arya R, Gulati S, Kabra M, et al. Intranasal versus intravenous lorazepam for control of acute seizures in children: A randomized open-label study. Epilepsia. 2011;52(4):788-93.
Sreenath TG, Gupta P, Sharma KK, Krishnamurthy S. Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. Eur J Paediatr Neurol. 2010;14(2):162-8.
Lewena S, Pennington V, Acworth J, et al. Emergency management of pediatric convulsive status epilepticus: A multicenter study of 542 patients. Pediatr Emerg Care. 2009;25(2):83-7.
Mpimbaza A, Ndeezi G, Staedke S, et al. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: A randomized clinical trial. Pediatrics. 2008;121(1):e58-64.
Chin RF, Neville BG, Peckham C, et al. Treatment of community-onset, childhood convulsive status epilepticus: A prospective, population-based study. Lancet Neurol. 2008;7(8):696-703.
Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: A randomized controlled trial. J Child Neurol. 2007;22(10):1191-7.
Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16(6):527-32.
Teng D, Dayan P, Tyler S, et al. Risk of intracranial pathologic conditions requiring emergency intervention after a first complex febrile seizure episode among children. Pediatrics. 2006;117(2):304-8.
Tay SK, Hirsch LJ, Leary L, et al. Nonconvulsive status epilepticus in children: Clinical and EEG characteristics. Epilepsia. 2006;47(9):1504-9.
Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: A pilot study. Neurology. 2006;67(2):340-2.
Shah I, Deshmukh CT. Intramuscular midazolam vs intravenous diazepam for acute seizures. Indian J Pediatr. 2005;72(8):667-70.
McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: A randomised controlled trial. Lancet. 2005;366(9481):205-10.
Chin RF, Neville BG, Scott RC. Meningitis is a common cause of convulsive status epilepticus with fever. Arch Dis Child. 2005;90(1):66-9.
Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav. 2004;5(2):253-5.
Yu KT, Mills S, Thompson N, Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia. 2003;44(5):724-6.
Fişgin T, Gurer Y, Teziç T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: Prospective randomized study. J Child Neurol. 2002;17(2):123-6.
Lahat E, Goldman M, Barr J, et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: Prospective randomised study. BMJ. 2000;321(7253):83-6.